MAPT and Alzheimer disease: Collectively, these findings highlight zinc dyshomeostasis as a multifaceted driver of AD pathology, involving Aβ deposition, tau hyperphosphorylation, oxidative stress, and neuroimmune modulation [11,15,17,19].